Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Propofol and remifentanil requirements after acute ethanol intake in clinical settings
ISRCTN ISRCTN73421343
ClinicalTrials.gov identifier
Public title Propofol and remifentanil requirements after acute ethanol intake in clinical settings
Scientific title
Acronym PRAECS
Serial number at source N/A
Study hypothesis Null hypothesis:Patients receiving intravenous ethanol would not require smaller doses of propofol and remifentanil for induction and maintenance of anaesthesia.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Greece
Disease/condition/study domain Interaction of acute ethanol intravenous intake with propofol (general anesthetic) and remifentanil (opioid)
Participants - inclusion criteria Female surgical patients on general anesthesia
Participants - exclusion criteria Alcoholic patients, patients in abstinence
Anticipated start date 02/02/2004
Anticipated end date 07/06/2004
Status of trial Completed
Patient information material
Target number of participants 60
Interventions Comparison of two groups (with different ethanol doses) versus control (no ethanol), regarding propofol and remifentanil requirements
Primary outcome measure(s) Reduction of propofol and remifentanil requirements
Secondary outcome measure(s) Degree of reduction, side-effects
Sources of funding Theagenio Anticancer Hospital of Thessaloniki (Greece)
Trial website
Publications
Contact name Dr  Fotis  Kanakoudis
  Address Korytsas 14
  City/town Thessaloniki
  Zip/Postcode 55133
  Country Greece
  Tel +30 2310437531
  Email fkanak@otenet.gr
Sponsor Theagenio Anticancer Hospital of Thessaloniki (Greece)
  Address Al. Symeonidis 2
  City/town Thessaloniki
  Zip/Postcode 54007
  Country Greece
  Tel +30 2310898213
  Email amitragas@yahoo.com
  Sponsor website: http://www.theagenio.gr
Date applied 30/06/2005
Last edited 14/09/2009
Date ISRCTN assigned 08/07/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central